898.7500 11.40 (1.28%)
NSE Jun 27, 2025 15:31 PM
Volume: 668.4K
 

898.75
1.28%
ICICI Securities Limited
Strides Pharma Science’s (Strides) Q3FY23 performance fell short of our revenue expectations, mainly due to negligible sales in the institutional business. Revenues grew 8.9% YoY (-3.6% QoQ) to Rs.8.7bn (I-Sec: Rs10bn).
Strides Pharma Science Ltd. has gained 25.68% in the last 1 Month
More from Strides Pharma Science Ltd.
Recommended